Monitor Owen Mumford's Aidaptus product sales performance over the next three years, as this will determine whether Embecta pays the full £50 million earn-out. The acquisition positions Embecta to expand in the drug-delivery device market, particularly in obesity, diabetes, and autoimmune disease treatments.
Price Chart
Executive Summary
Embecta Corp. (EMBC) has agreed to acquire Owen Mumford Holdings Limited, a UK-based medical device manufacturer, in a deal valued at up to £150 million. The transaction includes an upfront payment of £100 million and up to £50 million in earn-out payments tied to sales of the Aidaptus auto-injector platform. The acquisition is expected to expand Embecta's product portfolio and commercial reach in chronic care markets.
Key Financial Metrics
Key Facts
- Embecta is acquiring Owen Mumford Holdings Limited for up to £150 million
- The deal includes an upfront payment of £100 million and up to £50 million in earn-out payments
- Earn-out payments are tied to net sales of the Aidaptus auto-injector platform over three years
- Owen Mumford generated £69.4 million in net revenue during fiscal year 2025
- The acquisition is expected to close in Embecta's fiscal third quarter of 2026
- Embecta expects the acquisition to contribute to revenue growth in fiscal year 2027 and beyond
Financial Impact
Up to £150 million total deal value, with £100 million upfront and £50 million in potential earn-outs
Risk Factors
- Integration challenges between the two companies
- Failure to achieve the sales targets needed to realize the full earn-out value
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000947871-26-000310 |
| Document: ss6090062_8k.htm | 0000947871-26-000310 |
| Document: ss6090062_ex9901.htm | 0000947871-26-000310 |
| Document: 0000947871-26-000310-index-headers.html | 0000947871-26-000310 |
| Document: 0000947871-26-000310-index.html | 0000947871-26-000310 |
| Document: 0000947871-26-000310.txt | 0000947871-26-000310 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Institutional Cluster | $5.59 $6.42 | ▼ −14.85% | ▼ −15.41% | $6.80 (−21.65%) |
Sep 4, 2026 7w ago | 144 | $5.80 $5.88 | ▲ +1.38% | ▲ +0.78% | $6.80 (+17.24%) |
Aug 13, 2026 10w ago | Insider Cluster | $5.11 $4.94 | ▼ −3.33% | ▼ −1.58% | $6.80 (+33.07%) |
Aug 7, 2026 11w ago | 8-K | $4.42 $5.80 | ▲ +31.22% | ▲ +31.62% | $6.80 (+53.85%) |
Aug 7, 2026 11w ago | Press Release | $4.42 $5.80 | ▲ +31.22% | ▲ +31.62% | $6.80 (+53.85%) |
Jul 23, 2026 13w ago | Press Release | $3.29 $5.23 | ▲ +58.97% | ▲ +55.34% | $6.80 (+106.69%) |
Jun 16, 2026 18w ago | Press Release | $3.09 $3.10 | ▲ +0.32% | ▲ +0.12% | $6.80 (+120.06%) |
Jun 11, 2026 19w ago | Institutional Cluster | $3.08 $3.18 | ▲ +3.25% | ▲ +1.36% | $6.80 (+120.78%) |
May 15, 2026 23w ago | 8-K | $3.14 $3.13 | ▼ −0.32% | ▼ −2.44% | $6.80 (+116.56%) |
May 5, 2026 24w ago | 8-K | $3.90 $3.49 | ▲ +10.51% | ▲ +15.47% | $6.80 (−74.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers